New Research Uncovers Delayed Effects of Genetic Mutation in Huntington's Disease Development

Scientists are delving into the complexities of Huntington's disease, a hereditary disorder that causes nerve cells in the brain to deteriorate. Although the genetic mutation responsible for Huntington's has been known for some time, the reason it manifests later in life despite being present from birth has remained unclear. Recent studies reveal that this mutation is initially harmless but grows over time, eventually producing toxic proteins that damage brain cells.

Huntington's disease symptoms, such as involuntary movements and cognitive decline, typically appear between ages 30 and 50. These symptoms worsen over a span of 10 to 25 years. Researchers from the Broad Institute of MIT and Harvard, McLean Hospital, and Harvard Medical School examined brain tissue from 53 individuals with Huntington's and 50 without. They analysed half a million cells to understand the mutation better.

Understanding DNA Repeats

The research focused on a specific gene where a three-letter DNA sequence, CAG, repeats at least 40 times in those with Huntington's. In unaffected individuals, this sequence repeats only 15 to 35 times. The study found that these DNA tracts expand over time, reaching hundreds of CAGs in length. When they surpass about 150 repeats, certain neurons begin to die.

"The findings were really surprising, even to us," said Steve McCarroll, a Broad member and co-senior author of the study published in Cell. The study received partial funding from the Howard Hughes Medical Institute, which also supports The Associated Press Health and Science department.

Implications for Treatment

The research team noted that repeat tracts grow slowly during the first two decades of life but accelerate significantly after reaching around 80 CAGs. "The longer the repeats, the earlier in life the onset will happen," explained neuroscience researcher Sabina Berretta, one of the study's senior authors.

Initially, some scientists were sceptical about these findings presented at conferences. Previous studies suggested that expansions between 30 and 100 CAGs were necessary but not sufficient to cause Huntington's. McCarroll acknowledged that fewer than 100 CAGs are insufficient to trigger the disease but stated that expansions with at least 150 CAGs are.

Future Research Directions

Researchers hope their discoveries will aid in developing methods to delay or prevent this incurable condition affecting approximately 41,000 Americans. Current treatments focus on managing symptoms with medication. Experimental drugs aimed at reducing protein levels produced by the mutated gene have faced challenges in trials.

The new findings suggest that slowing or halting DNA repeat expansion might be a more effective approach. Although there are no guarantees this would prevent Huntington's, McCarroll mentioned that "many companies are starting or expanding programs to try to do this."